Parabolko 150

COMPOSITION:

Each ml contains: Trenbolone Hexahydrobenzylcarbonate 150 mg
Oil Base.........q.s.

DESCRIPTION:

Parabolko 150 is an oil based solution of Trenbolone Hexahydrobenzylcarbonate for IM injection. Trenbolone Hexahydrobenzylcarbonate is a man-made steroid, similar to the naturally occuring steroid testosterone. Trenbolone promotes significant increase in strength, muscle anabolism, appetite, and aggression and has been demonstrated to reduce body fat.

CLINICAL PHARMACOLOGY:

Endogenous androgens such as testosterone or derivatives are responsible for the development and growth of the male sexual organs and post-adolescent secondary sex characteristics. Androgen effects include but are not limited to the maturation of the penis, scrotum, prostate, seminal tubules, laryngeal enlargement, vocal cord thickening, changes in muscle mass and fat distribution, and the development and distribution of male hair (facial, pubic, chest, back, axillary). Androgens have been linked to increased protein anabolism and consequent decreased protein catabolism. Androgens increase retention of sodium, potassium, and phosphorus. Androgens decrease urinary excretion of calcium. Androgens are responsible for the growth spurt of adolescence and the aromatization of androgens to estrogens for the eventual termination of linear growth, which is brought about by fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates but may cause a disproportionate advancement in bone maturation. Use over long periods may result in fusion of the epiphyseal growth centers and termination of the growth process. Androgens have been reported to stimulate the production of red blood cells by enhancing the production of erythropoietin stimulating factor. Androgens may suppress gonadotrophic function of the pituitary. During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). With large doses, spermatogenesis may be suppressed through feedback inhibition of pituitary follicle stimulating hormone (FSH).

INDICATION AND USAGE :

Males: Androgen Replacement Therapy: Trenbolone is used to promote weight gain following extensive surgery, chronic infection, or severe trauma, and in other cases that result in inadequate weight gain or maintenance. Trenbolone Hexahydrobenzylcarbonate is also used to decrease muscle loss caused by treatment with corticosteroids and to reduce bone pain associated with osteoporosis.

CONTRAINDICATIONS :

Diagnosed or suspected carcinoma of the male breast or prostate. Women who are pregnant or may become pregnant because of possible masculinization of the fetus. When administered to pregnant women, androgens cause virilization of the external genitalia of the female fetus. This virilization includes clitoromegaly, abnormal vaginal development, and fusion of genital folds to form a scrotal-like structure. Patients with a history of hypersensitivity to Trenbolone or any of its components. Patients with serious renal, cardiac, or hepatic dysfunction.

WARNINGS:

This product can be used only by healthy adults over 18 years old. Carefully read directions before using this product. Consult your physician before using this product if you are taking any prescription or over the counter drugs or supplements. KEEP AWAY FROM CHILDREN.

SIDE EFFECTS:

Males: Frequent or persistent penile erections and increases in the appearance of acne vulgaris. Females: Hoarseness of the voice, acne, changes in menstrual periods, or more facial hair. All patients: Nausea, vomiting, changes in skin color, or ankle swelling. Laboratory Tests and Patient Monitoring: Examination of bone age by x-ray should be conducted during treatment of children to determine bone maturation rate and effect on epiphyseal centers. Women with breast carcinoma should have frequent assays of serum and urine calcium throughout the course of treatment. Androgens have been associated with increases in low-density lipoproteins and reduction in high-density lipoproteins in serum. Periodic serum lipid assays are recommended during treatment.

DOSAGE AND ADMINISTRATION:

Adult male: 150 mg injected intramuscularly (IM) 1 to 3 times per week for duration limited to 4 weeks under care of physician

STORAGE:

Do not refrigerate or freeze. Do not store above 30 C. Protect from direct sunlight.

PACKAGE:

10 x 1 ml Ampoule